Evaluation of the Efficacy and Effectiveness of Hysteroscopic Electroresection in the Treatment of Submucosal Uterine Fibroids
Download PDF

Keywords

Submucosal uterine fibroids
Hysteroscopic electroresection
Treatment effect

DOI

10.26689/jcnr.v8i3.6300

Submitted : 2024-02-23
Accepted : 2024-03-09
Published : 2024-03-24

Abstract

Objective: To evaluate the effect of hysteroscopic electroresection in treating submucosal uterine fibroids. Methods: Using the random number table method, 70 patients with submucosal uterine fibroids were divided into two groups, 35 cases/group. The control group underwent laparoscopic myomectomy, and the observation group underwent hysteroscopic electroresection. Surgical indicators, sex hormone indicators, inflammation indicators, and treatment effects were compared between the two groups. Results: The surgical indicators, sex hormone indicators, and inflammatory indicators three months after operation in the observation group were all more ideal than those of the control group. The total effective rate of the observation group (97.14%) was higher than that of the control group (P < 0.05). Conclusion: Hysteroscopic electroresection for the treatment of submucosal uterine fibroids was less invasive, accelerates recovery, and is more effective.

References

Guo Y, Liu L, Li J, et al., 2020, Comparison of the Efficacy of Hysteroscopic Electroresection and Laparoscopic Myomectomy in the Treatment of Patients with Submucosal Uterine Fibroids and Infertility. Inner Mongolia Medical Journal, 52(3): 267–269.

Chen C, 2020, Clinical Effect of Hysteroscopic Uterine Fibroid Electroresection in Treating Submucosal Fibroids. Chinese Contemporary Medicine, 27(17): 118–121.

Peng F, Ke Y, Shen L, et al., 2020, The Application Value of Hysteroscopic Electroresection in the Treatment of Submucosal Uterine Fibroids. Jilin Medicine, 41(3): 663–664.

Bing X, 2020, Analysis of the Clinical Efficacy and Prognosis of Hysteroscopic Electroresection in the Treatment of Submucosal Uterine Fibroids. Chinese Modern Drug Application, 14(19): 92–94.

Lu D, 2020, Analysis of the Efficacy and Safety of Ultrasound-Guided Hysteroscopic Electroresection in Treating Submucosal Uterine Fibroids. Capital Food and Medicine, 27(17): 28.

Sun D, 2023, Observation on the Efficacy of Hysteroscopic Electroresection in the Treatment of Submucosal Uterine Fibroids. Chinese Modern Drug Application, 17(4): 68–70.

Feng Y, 2023, Discussion on the Efficacy of Hysteroscopic Uterine Fibroid Electroresection in Patients with Uterine Submucosal Fibroids and its Impact on Ovarian Reserve Function. Chinese Practical Medicine, 18(14): 52–54.

Sheng L, 2022, Effect of Hysteroscopic Electroresection Under Ultrasound Supervision in the Treatment of Patients with Submucosal Uterine Fibroids. Chinese Journal of Civil Health, 34(7): 25–27.

Zhang C, Yang Y, 2022, The Effect of Hysteroscopic Uterine Fibroid Electroresection in Treating Uterine Submucosal Fibroids and its Impact on Patients’ Ovarian Reserve Function. Clinical Medical Research and Practice, 7(22): 88–90.

Wang L, Liu R, 2021, Efficacy of Hysteroscopic Electroresection in the Treatment of Submucosal Uterine Fibroids and Perioperative Blood Flow Changes. Thrombosis and Hemostasis, 27(5): 835–836.

Zhao Y, 2021, Analysis of the Efficacy and Safety of Hysteroscopic Electroresection Under Ultrasound Surveillance in Treating Submucosal Uterine Fibroids. Henan Medical Research, 2021, 30(25): 4721–4723.

Zhang H, 2023, Effects of Hysteroscopic Submucosal Uterine Fibroids and Polyps Electroresection on Reproductive Prognosis and Ovarian Function Recovery in Patients with Submucosal Uterine Fibroids. Marriage, Childbirth and Health, 29(8): 16–18.

Zhang F, 2022, The Efficacy of Hysteroscopic Uterine Fibroid Electroresection in Treating Uterine Submucosal Fibroids. Journal of Shanxi Health Vocational College, 2022, 32(4): 22–24.

Zhang L, Luo S, 2022, Clinical Effect of Hysteroscopic Electroresection in the Treatment of Submucosal Uterine Fibroids and Its Impact on Patients’ Sex Hormone Levels and Ovarian Reserve Function. Clinical Medical Research and Practice, 7(21): 94–97.